AstraZeneca Sues Pharmacy Over “Bait And Switch” Tactic With Popular Asthma Drug

Law360, New York (September 6, 2005, 12:00 AM EDT) -- AstraZeneca has sued a manufacturer for trademark infringement and false advertising under the Lanham Act, alleging a copycat version of its inhaled asthma medication Pulmicort Respules is forced on unsuspecting customers.

Connecticut-based Broncho-Dose is a mail order “repertory pharmacy” that allegedly engages in the “often abused practice” of pre-mixing its own non-FDA-approved drugs, according to the complaint. Broncho then distributes the drugs as substitutes for various products, including the product in this suit.

Delaware-based AstraZeneca does not allege the Broncho version of the medication is too...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.